These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6663183)

  • 1. [Intraglomerular coagulation in patients with glomerulonephritis, with special reference to FDP D-dimer].
    Shibata T; Ura S; Hirai Y; Taura K; Harada T; Hara K
    Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1143-9. PubMed ID: 6663183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh
    Lab Delo; 1977; (8):451-4. PubMed ID: 72846
    [No Abstract]   [Full Text] [Related]  

  • 5. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
    Nakamichi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy.
    Colasanti G; Morel Maroger L; D'Amico G
    Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on intraglomerular coagulation in various renal diseases].
    Shibata T
    Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1535-47. PubMed ID: 3831470
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
    Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
    Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
    [No Abstract]   [Full Text] [Related]  

  • 12. Defibrination of intraglomerular fibrin deposits by urokinase in patients with IgA nephropathy.
    Tomino Y; Miura M; Suga T; Endoh M; Nomoto Y; Sakai H
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):275-80. PubMed ID: 6748339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation and glomerular nephritis].
    Hatano M; Kaizu K
    Nihon Rinsho; 1981; 39(12):3674-9. PubMed ID: 7339027
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical diagnosis of blood coagulation in the kidney glomerulus].
    Taura K; Harada K
    Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):829-31. PubMed ID: 6663850
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of extravasation in pelvic fracture using coagulation biomarkers.
    Aoki M; Hagiwara S; Tokue H; Shibuya K; Kaneko M; Murata M; Nakajima J; Sawada Y; Isshiki Y; Ichikawa Y; Oshima K
    Injury; 2016 Aug; 47(8):1702-6. PubMed ID: 27267962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary fibrinogen derivative excretion and intraglomerular fibrin deposition in glomerulonephritis.
    Naish P; Evans DJ; Peters DK
    Br Med J; 1974 Mar; 1(5907):544-6. PubMed ID: 4593708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the evidence for activated coagulation in glomerulonephritis?
    Andrassy K; Ritz E; Mauerhoff T; Bommer J
    Am J Nephrol; 1982; 2(6):293-300. PubMed ID: 6819778
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrin and fibrinogen degradation products (FDP) in renal diseases. II. Serum and urinary FDP in different morphological forms of glomerulonephritis].
    Ratajczak T; Rabczyński J; Szewczyk Z
    Pol Arch Med Wewn; 1978 Apr; 59(4):429-40. PubMed ID: 662758
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical usefulness of the measurement of plasma D-dimer levels].
    Suehiro A; Koyama T
    Rinsho Byori; 1991 Jul; 39(7):694-700. PubMed ID: 1920861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.